Variant | Gene | Risk Allele | Score vda | Association Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||
---|---|---|---|---|---|---|---|---|---|---|
|
A | 0.740 | GeneticVariation | GWASCAT | Association analysis identifies 65 new breast cancer risk loci. | 29059683 | 2017 |
|||
|
A | 0.740 | GeneticVariation | GWASCAT | Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer. | 25751625 | 2015 |
|||
|
0.740 | GeneticVariation | BEFREE | Genome-wide association studies have identified novel breast cancer susceptibility loci at 12q24 (rs1292011), 12p11 (rs10771399) and 21q21 (rs2823093). | 25476496 | 2015 |
||||
|
0.740 | GeneticVariation | BEFREE | We found that rs10771399 and rs1292011 were significantly associated with risk of breast cancer with per-allele odds ratios (ORs) of 0.85 (95% confidence interval (CI): 0.76-0.96; P = 0.010) and 0.84 (95% CI: 0.76-0.95; P = 4.50×10(-3)), respectively, which was consistent with those reported in populations of European descent. | 23776684 | 2013 |
||||
|
A | 0.740 | GeneticVariation | GWASCAT | Large-scale genotyping identifies 41 new loci associated with breast cancer risk. | 23535729 | 2013 |
|||
|
0.740 | GeneticVariation | BEFREE | We identified three new breast cancer risk loci at 12p11 (rs10771399; P = 2.7 × 10(-35)), 12q24 (rs1292011; P = 4.3 × 10(-19)) and 21q21 (rs2823093; P = 1.1 × 10(-12)). rs10771399 was associated with similar relative risks for both estrogen receptor (ER)-negative and ER-positive breast cancer, whereas the other two loci were associated only with ER-positive disease. | 22267197 | 2012 |
||||
|
0.740 | GeneticVariation | BEFREE | Recent genome-wide association studies of breast cancer have identified eight additional breast cancer susceptibility loci: rs1011970 (9p21, CDKN2A/B), rs10995190 (ZNF365), rs704010 (ZMIZ1), rs2380205 (10p15), rs614367 (11q13), rs1292011 (12q24), rs10771399 (12p11 near PTHLH) and rs865686 (9q31.2). | 22348646 | 2012 |